Better Therapeutics, Inc. (BTTX) Debt-to-equity % [USD] 2021 - 2023

Historical data

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Better Therapeutics, Inc. quarterly Debt-to-equity history and growth rate from 2021 to 2023.
Better Therapeutics, Inc. Debt-to-equity for the quarter ending September 30, 2023 was -285 %, a 479% decline year-over-year.

Debt-to-equity, Quarterly Data (% [USD])

Period	Value	YoY Chg	Change %	Date
Q3 2023	-285	-360	-479%	Sep 30, 2023
Q2 2023	-630	-728	-738%	Jun 30, 2023
Q1 2023	594	+290	+95.2%	Mar 31, 2023
Q4 2022	148	+219		Dec 31, 2022
Q3 2022	75	+102		Sep 30, 2022
Q2 2022	98.6			Jun 30, 2022
Q1 2022	304			Mar 31, 2022
Q4 2021	-71.1			Dec 31, 2021
Q3 2021	-27			Sep 30, 2021

* An asterisk sign (*) next to the value indicates that the value is likely invalid.